吴一龙. 抗肿瘤血管生成剂临床试验的循证思考[J]. 循证医学, 2002, 2(2): 65-66. DOI: 10.3969/j.issn.1671-5144.2002.02.001
    引用本文: 吴一龙. 抗肿瘤血管生成剂临床试验的循证思考[J]. 循证医学, 2002, 2(2): 65-66. DOI: 10.3969/j.issn.1671-5144.2002.02.001
    Evidence based thinking for clinical trials of anti-tumor angiogenic agents[J]. Journal of Evidence-Based Medicine, 2002, 2(2): 65-66. DOI: 10.3969/j.issn.1671-5144.2002.02.001
    Citation: Evidence based thinking for clinical trials of anti-tumor angiogenic agents[J]. Journal of Evidence-Based Medicine, 2002, 2(2): 65-66. DOI: 10.3969/j.issn.1671-5144.2002.02.001

    抗肿瘤血管生成剂临床试验的循证思考

    Evidence based thinking for clinical trials of anti-tumor angiogenic agents

    /

    返回文章
    返回